Organon shareholders approve merger with Sun Pharma; 98.7% of votes cast in favor

Organon & Co.

Proposal to adopt merger agreement passed with 192,776,552 votes for, 2,573,118 against, 326,189 abstaining.
Advisory vote on merger-related executive compensation approved: 185,141,986 for, 9,553,830 against, 980,043 abstaining.
74.51% of outstanding shares (195,675,859) were represented at the July 23, 2026 special meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.